Skip to content

Drug interactions

Insulin glargine-lixisenatide + Lonapegsomatropin

Severity: Moderate

Insulin glargine-lixisenatide and Lonapegsomatropin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Growth hormone reduces insulin sensitivity, especially at higher doses, and can raise blood glucose. Patients with diabetes may need higher doses of insulin or other antidiabetic drugs.

What this interaction means in plain words

Insulin glargine-lixisenatide and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Insulin glargine-lixisenatide belongs to Endocrine; Lonapegsomatropin belongs to Endocrine.

Evidence level: High

Why it happens

Pharmacodynamic antagonism through growth hormone-induced insulin resistance.

What to do

Monitor blood glucose when starting or adjusting the growth hormone dose and increase antidiabetic therapy as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Insulin glargine-lixisenatide and Lonapegsomatropin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Insulin glargine-lixisenatide with Lonapegsomatropin?

MediHelp rates the interaction as moderate. Insulin glargine-lixisenatide and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Growth hormone reduces insulin sensitivity, especially at higher doses, and can raise blood glucose. Patients with diabetes may need higher doses of insulin or other antidiabetic drugs.

How serious is the interaction between Insulin glargine-lixisenatide and Lonapegsomatropin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when starting or adjusting the growth hormone dose and increase antidiabetic therapy as needed.

What other medicines interact with Insulin glargine-lixisenatide?

MediHelp also lists interactions of Insulin glargine-lixisenatide with, for example, Albiglutide, Chlorpropamide, Dulaglutide. The full list is on the Insulin glargine-lixisenatide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in